NCT03646877View on ClinicalTrials.gov

Mechanisms of Ozone-Induced Alterations in Efferocytosis and Phagocytosis

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

March 19, 2019

Primary Completion Date

July 26, 2023

Study Completion Date

July 27, 2023

Conditions
Healthy
Interventions
DRUG

Ozone

Subjects will perform alternating 15 minutes rest with 15 minutes treadmill walk exercise periods for 135 minutes in while breathing Ozone (O3).

OTHER

Filtered Air

Subjects will perform alternating 15 minutes rest with 15 minutes treadmill walk exercise periods for 135 minutes in while breathing filtered air.

Trial Locations (1)

27710

Duke University Medical Center, Durham

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

Ohio State University

OTHER

lead

Robert Tighe, MD

OTHER

NCT03646877 - Mechanisms of Ozone-Induced Alterations in Efferocytosis and Phagocytosis | Biotech Hunter | Biotech Hunter